2014
DOI: 10.1111/ics.12160
|View full text |Cite
|
Sign up to set email alerts
|

Physical characterization and in vitro skin permeation of solid lipid nanoparticles for transdermal delivery of quercetin

Abstract: The results suggest that QSLN-2, prepared with a surfactant content of 2%, could be used as useful skin delivery system for transdermal delivery of hydrophobic antioxidants such as quercetin.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
21
0
1

Year Published

2015
2015
2020
2020

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 60 publications
(25 citation statements)
references
References 28 publications
2
21
0
1
Order By: Relevance
“…The number of studies about the encapsulation of quercetin in lipid microparticles (nano or micro) has been increasing in the last five years (Li et al, 2009;Dhawan et al, 2011;Weiss-Angeli et al, 2012;Pool et al, 2013;Aditya et al, 2014;Han et al, 2014), but most studies have not evaluated the stability of encapsulated quercetin over the storage period. Scalia & Mezzena (2009) evaluated the stability of encapsulated quercetin in lipid microparticles that were composed of tristearin as the solid core and phosphatidylcholine as the surfactant, which were produced using ultra-agitation (mean diameters of 15-45 ฮผm), and they found that 85% of the flavonoid remained in the particles after 90 days of storage in the dark.…”
Section: Physico-chemical Characterization and Stability Along The Stmentioning
confidence: 99%
“…The number of studies about the encapsulation of quercetin in lipid microparticles (nano or micro) has been increasing in the last five years (Li et al, 2009;Dhawan et al, 2011;Weiss-Angeli et al, 2012;Pool et al, 2013;Aditya et al, 2014;Han et al, 2014), but most studies have not evaluated the stability of encapsulated quercetin over the storage period. Scalia & Mezzena (2009) evaluated the stability of encapsulated quercetin in lipid microparticles that were composed of tristearin as the solid core and phosphatidylcholine as the surfactant, which were produced using ultra-agitation (mean diameters of 15-45 ฮผm), and they found that 85% of the flavonoid remained in the particles after 90 days of storage in the dark.…”
Section: Physico-chemical Characterization and Stability Along The Stmentioning
confidence: 99%
“…With these features, SLN formulations have the potential to improve the bioavailability and stability of drugs for topical therapy . Therefore, SLN have been intensively explored for drug delivery in the last decade and have been studied for different routes of administration; oral, ocular, nasal, topical, for both local, and systemic effect; however, only few works have been introducing their use for treatment of buccal mucosal diseases, in which Karavana et al introduced a new approach for the treatment of recurrent aphthous stomatitis using SLNโ€containing cyclosporine, dispersed in a gel matrix.…”
Section: Introductionmentioning
confidence: 99%
“…Next, the cells were washed three times with cold PBS and stained with 4 ,6-diamidino-2-phenylindole (DAPI). Later, the coverslips were visualized using a laser scanning confocal microscope (LSCM, Leica TCS SP8 X, Wetzlar, Germany) using appropriate excitation and emission wavelengths (405/450 nm for DAPI and 470/504 nm for Cou-6) [38,39]. In Vitro Cytotoxicity Analysis Cytotoxicity of the CAT3 suspension, OA-CAT3-SLN, and blank SLN against the C6 brain glioma cell line was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide (MTT) assay.…”
Section: In Vitro Cellular Uptake Studymentioning
confidence: 99%